Dow Down3.39% Nasdaq Down4.12%

Transgenomic Inc. (TBIO)

-NasdaqCM
0.55 Down 0.04(6.84%) 4:00PM EDT
|After Hours : 0.55 Up 0.01 (1.38%) 4:07PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015
Total Revenue 236   117   12,803   750  
Cost of Revenue505  (975)7,242  465  
Gross Profit (269) 1,092   5,561   285  
Operating Expenses
Research Development270  561  692  451  
Selling General and Administrative1,704  2,143  8,323  1,804  
Non Recurring -  7,024   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,243) (8,636) (3,454) (1,970)
Income from Continuing Operations
Total Other Income/Expenses Net321  379  (270)(158)
Earnings Before Interest And Taxes(1,922)(8,257)(3,724)(2,128)
Interest Expense169  174  186  190  
Income Before Tax(2,091)(8,431)(3,910)(2,318)
Income Tax Expense -  (554)88   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,091)(7,877)(3,998)(2,318)
Non-recurring Events
Discontinued Operations(1,173)578  723  (723)
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,264) (7,299) (3,275) (3,041)
Preferred Stock And Other Adjustments(21)(331)(331)(331)
Net Income Applicable To Common Shares (3,285) (7,630) (3,606) (3,372)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.